The FTSE 100 has fallen 11% in a week. Here’s my contrarian pick

Here’s a cyclical stock that I believe can hold investors in good stead. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s a bad time for stock markets. The coronavirus scare has gripped global markets, leading to a sharp plunge. The FTSE is no exception to this. The FTSE 100 index has fallen by more than 11% in a week, and it might fall even more next week. The unfortunate spread of COVID-19 shows no sign of slowing. It’s easy to think of the worst that can happen at this time, get nervous, and sell off. Or, at the very least, refrain from buying.  

Alternative view 

But consider another perspective. What if the virus were to be contained in the near future? The panicked drop in share prices will look like a time when investments should have been made. Even if markets continue to drop, the fact remains that a number of high-growth and high-dividend stocks are available at huge discounts right now. These stocks have a gravity defying track-record. In other words, there’s limited risk to holding them in our investing portfolio.  

Real estate in focus 

One of these is the FTSE 100 house-builder Persimmon (LSE: PSN), whose share price has fallen by 13.8% since last week. It may sound contrarian to suggest a cyclical stock at a time when economic conditions could take a turn for the worse. But there are three reasons why I still like it.  

One, sure, the stock shows cyclicality in the near term but over the longer term, it’s more likely than not to allow for significant capital gains. Two, it’s one of the only stocks to provide both capital growth and a high passive income. At present, its dividend yield is 8.2%. It also intends to maintain its current level of dividends in the next year at least. With a falling share price, we are essentially looking at potentially even higher yields going forward. Three, UK’s real estate market is picking up, which bodes well for stocks in the sector.  

Not always contrarian 

Outside of real estate, however, I do agree that going contrarian isn’t always the best idea. Last week, I had written about how I’d stay away from financials in the case of a stock market crash. It seemed less likely then, but today I’d start to become more cautious of the sector. 

There are plenty of less contrarian stocks to invest in in any case. Pharmaceuticals and healthcare companies like GlaxoSmithKline and Smith & Nephew are two that I like. Yesterday, I had also written about Diageo, the FTSE 100 alcohol producer, which has been a good investment over the past years. It has warned of the impact on its profits as a result of the virus outbreak, but it’s too soon to say if there will be any longer-term impact on the stock. In this scenario, I’m sticking to Warren Buffett’s advice by getting greedy when others are fearful.       

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Diageo. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Charticle

2 brilliant (but very different) shares I want to buy if they get cheaper in 2025!

This contrasting pair of businesses has caught our writer's eye. But he is not ready to buy the shares at…

Read more »

Investing Articles

3 steps to start buying shares with a spare £250

Christopher Ruane explains three simple but important principles he thinks people should consider when they start buying shares, even with…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

FTSE 100 shares: bargain hunting to get richer!

After hitting a new high this year, might the FSTE 100 still offer bargain shares to buy? Our writer thinks…

Read more »

Investing Articles

How to try and turn a £50K SIPP into a £250K retirement fund

Christopher Ruane explains how a long-term approach and careful share selection could potentially help an investor quintuple the value of…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

My £3 a day passive income plan for 2025

Christopher Ruane walks through his plan for next year and beyond of squirreling away and investing a few pounds a…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Can the FTSE 250’s Raspberry Pi boost my portfolio over the next decade?

This British technology stock in the FTSE 250 has exploded onto the London stock market and right now its future…

Read more »

Investing Articles

Does acquiring Direct Line make Aviva shares a buy?

A big acquisition should give Aviva greater scale and profitability, increasing the value of its shares. But is it an…

Read more »

Investing Articles

After a 25% decline in 2024, this FTSE 250 stock is top of my buy list for the New Year

Stephen Wright’s top investment idea is a FTSE 250 stock that’s down 25% this year in an industry that’s under…

Read more »